Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Charlotte, 50, a UK events manager, was struggling with her weight and menopause symptoms before turning to the groundbreaking device ...

Weight loss jabs such as Wegovy are “lifelong treatments” and most people who stop taking them will lose the effects, a scientist who developed the revolutionary drugs has said. Professor ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...

Moreover, the list of 15 is expected to include the blockbuster drug semaglutide, the GLP-1 class drug behind the brand-name weight-loss and diabetes drugs Wegovy and Ozempic, made by Novo Nordisk.

but there are some dreadful side effects that come with the weekly self-administered pen injections. Nausea and vomiting are the most common symptoms but kidney and liver damage, gall bladder ...

Charlotte, 50, is an Events Manager who took up The Slimming Clinic’s weight loss programme and began using a Wegovy pen to support her goals. Wegovy is a weekly injection that aids with weight ...

The review also found that a GLP-1 drug still in development, called retatrutide, might be more effective than either Zepbound or Wegovy. “We found that, of the 12 GLP-1 (drugs) identified by ...